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Abstract With the increase in the number of cancer patients
worldwide in the coming years, the need for knowledge on the
influence of lifestyle factors on cancer survival is increasing.
In this paper, the current knowledge on diet, body mass index,
and physical activity in relation to cancer outcome is summa-
rized. Also, challenges are identified to be addressed to pro-
vide evidence-based recommendations for cancer patients.
Studies in patients with breast, colorectal, or prostate cancer
show that the influence of dietary factors on survival remains
to be determined. Adiposity and a lack of physical activity,
however, appear to influence cancer outcome negatively.
Subsequent studies should focus on more detailed aspects of
these lifestyle factors, such as body composition and dose of
exercise, and on the timing with respect to diagnosis and
treatment. Research should be directed toward investigating
diet and physical activity simultaneously and on how changes
in health behavior can be established.
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Introduction
Of all individuals who are diagnosed with cancer, more than
50% will live 5 years or longer after diagnosis [1, 2]. The
number of cancer survivors will increase steadily in the
coming years due to screening practices, more advanced
treatment options, and improved follow-up after treatment.
Besides functional limitations and psychosocial problems
related to cancer diagnosis and treatment, cancer survivors
face the possibility of second cancers, long-term effects of
cancer treatment, and comorbid conditions such as diabetes
and cardiovascular disease [3, 4]. Particularly relatively
soon after diagnosis or treatment, many patients will be
interested in dietary or other lifestyle changes that could
improve their prognosis.
We do know on the basis of more than 10,000 experimental
and observational studies that overweight, an unhealthy diet
(i.e., low in vegetables and fruits and high in [processed] red
meat), alcohol intake, and lack of physical activity significantly
influence the risk of developing certain types of cancer [5, 6].
However, what about those who have cancer? Does it still make
sense to change one’s lifestyle after cancer has been diagnosed?
Which lifestyle changes do cancer patients make and what
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should we recommend? In contrast to the wealth of current
evidence on the role of diet and physical activity in the etiology
of cancer, only a fewwell-designed studies have been conducted
thus far to assess whether similar modifiable risk factors influ-
ence outcomes of patients already diagnosed with cancer. Cur-
rent recommendations for cancer survivors are based on the
recommendations to reduce cancer risk and emphasize achiev-
ing and maintaining a healthy weight; regular physical activity;
and consumption of a diet rich in vegetables, fruit, and whole
grains and limited in redmeat and alcohol. Also, the use of foods
instead of supplements is recommended. However, it is ac-
knowledged that the evidence for these recommendations is
limited.
During the past decade, the focus of researchers as well
as funding agencies has broadened from cancer prevention
only to include cancer survival. The number of publications
on diet, physical activity, and cancer survivorship is rapidly
increasing [7]. During the past few years, results of these
studies have been extensively reviewed [8–16, 17••, 18–21].
This paper summarizes the conclusions from previous
reviews and discusses results from the most recent studies
on the role of diet, body mass index (BMI), and physical
activity before, during, and after treatment on cancer recur-
rence, cancer-specific death, and all-cause mortality. As the
majority of studies focused on three of the most frequently
occurring types of cancer in the Western world (i.e., breast,
colorectal, and prostate cancer), those types of cancer are
reviewed. In this paper, ongoing challenges and the next
steps that need to be taken are identified to provide
evidence-based recommendations for cancer survivors.
What Do We Know?
Breast Cancer
Diet
As reviewed by several authors, some, but not all, observa-
tional studies on breast cancer outcome showed favorable
effects of pre- and postdiagnosis high intake of vegetables,
fruits, and whole grains on overall death and death from non–
breast cancer causes, but not breast cancer–specific death
[17••, 21]. A few years ago, two large dietary intervention
studies were conducted among women diagnosed with breast
cancer: the WHEL (Women’s Healthy Eating and Living) and
the WINS (Women’s Intervention Nutrition Study) [22, 23].
WHEL focused on a plant-based dietary pattern that included
a reduction in dietary fat, while WINS focused on reduced
dietary fat intake. Overall, the results of these trials indicated
that dietary interventions among breast cancer survivors
without weight loss or increased physical activity are not
sufficient to improve breast cancer prognosis [22, 23].
Secondary analyses inWHEL showed that specific subgroups
may benefit from increased vegetable and fruit consumption
[24–26], but these results need to be confirmed by others.
Several recent observational studies focused on specific
components in plant foods and breast cancer outcome, such
as dietary fiber [27] and specific plant-based phytoestro-
gens. Buck et al. [28, 29••] recently investigated enterolac-
tone, the main metabolite of lignans, the most important
class of phytoestrogens in Western diets, and showed that
high estimated prediagnostic and postdiagnostic serum lev-
els were associated with increased overall survival in post-
menopausal breast cancer patients. The consumption of soy,
an important source of phytoestrogens in an Asian diet, in
relation to breast cancer outcome has been controversial, as
some previous studies showed harmful effects on breast
cancer recurrence [30]. Results from three recent studies
showed that postdiagnostic intake of isoflavone, the major
component of soy, was not associated with second breast
cancer risk and may decrease the risk of overall mortality
[31, 32••, 33]. Based on those findings, there is no need to
advise against soy consumption in breast cancer patients.
Although consumption of alcoholic drinks clearly
increases breast cancer risk, studies are not consistent
concerning alcohol and breast cancer outcomes [21]. Alco-
hol intake may increase risk of breast cancer recurrence and
breast cancer–related mortality, although this is not ob-
served in all studies. Moderate intake of alcohol after diag-
nosis may, however, decrease the risk of death from
comorbidities such as cardiovascular disease [21]. In 2010,
Kwan and coworkers [34••] published a study based on the
LACE (Life after Cancer) study, a prospective cohort study
including 1,897 women with early-stage breast cancer. The
authors observed that drinking 6 or more g/day (~one half of
a drink) of alcohol compared with no drinking after breast
cancer diagnosis was not associated with all-cause mortality.
However, it was associated with a decreased risk of non–
breast cancer mortality and an increased risk of recurrence
and breast cancer–specific death [34].
Vitamin D is postulated to be associated with decreased
cancer risk and improved survival [35••]. A nested case–
control study of 512 matched pairs within the WHEL study,
however, did not provide support for an association between
blood concentrations of 25-hydroxyvitamin D (25[OH]D)
after treatment and the recurrence of breast cancer. On the
other hand, a prospective cohort study conducted in Ger-
many and including 1,295 incident postmenopausal breast
cancer patients showed that lower 25(OH)D concentrations
(<35 nmol/L) were associated with poorer overall survival
and distant disease-free survival than higher concentrations
(≥55 nmol/L). The authors suggest that the relevant time
frame of and the effect of chemotherapy on serum 25(OH)D
measurements in breast cancer survival studies deserve fur-
ther investigation [36].
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Body Mass Index
It is certainly not new information that excess weight
among breast cancer patients increases the risk of contra-
lateral breast cancer, other primary cancers, and all-cause
mortality, as these topics have been reviewed extensively
over the past years [8, 17••, 19, 21, 35••]. A recent
retrospective study by Ewertz and colleagues [37] is prob-
ably the largest to date and included data from 18,967
women, all enrolled in adjuvant chemotherapy trials in
Denmark. It confirmed that obesity at diagnosis of early-
stage breast cancer is an independent prognostic factor for
the development of distant metastases and death after the
diagnosis of breast cancer [37].
Weight gain and changes in body composition are
known to be important side effects of certain breast
cancer treatments [38]. An increase in fat mass in com-
bination with a loss or no change in muscle mass is often
observed. Besides this “sarcopenic” obesity, chemothera-
py may impair muscle strength, which may lead to
“dynapenic” obesity. Weight gain as well as unfavorable
changes in body composition have been associated with
recurrence risk or decreased survival in some, but not all,
studies [38].
Physical Activity
Increased physical activity is associated with improved
breast cancer prognosis [8, 21]. In the large Women’s
Health Initiative study [39], the risk of all-cause and
breast cancer–specific mortality was decreased in post-
menopausal breast cancer survivors participating in mod-
erate to vigorous intensity recreational physical activity
(e.g., brisk walking, bicycling, or swimming) approxi-
mately 3 h/w before or after a breast cancer diagnosis
compared with nonactive women. Furthermore, the risk
of all-cause mortality declined by 33% in women who
increased their physical activity level to—or maintained
their level at—3 h or more per week (including women
who had been inactive at baseline) compared with wom-
en who stayed or became inactive. These findings sug-
gest that adopting an active lifestyle after diagnosis can
improve overall longevity and prognosis. This is in ac-
cordance with the recent findings from the After Breast
Cancer Pooling project, which included data from four
studies of breast cancer survivors (n013,302) [40]. En-
gaging in at least 10 metabolic equivalent task (MET) h/
week of physical activity postdiagnosis was associated
with a 27% reduction in all-cause mortality and a 25%
reduction in breast cancer mortality compared with wom-
en who were active for less than 10 MET h/week. Risk
of breast cancer recurrence was not associated with rec-
reational physical activity [40].
Colorectal Cancer
Diet
There are not enough studies on diet and outcomes in
colorectal cancer survivors to draw firm conclusions. More-
over, most studies were impaired by retrospective dietary
assessment, small patient groups, heterogeneous popula-
tions including all stages of disease, and/or limited capacity
to adjust for other prognostic factors. There is only one
prospective observational study, published a few years
ago, on postdiagnostic diet, BMI, and physical activity to
date among a relatively homogeneous population of 1,009
stage III colorectal cancer patients [41]. This study was
embedded in an adjuvant chemotherapy trial; diet was
assessed midway through therapy and 6 months after ther-
apy. A Western dietary pattern characterized by high intake
of red meat, fat, refined grains, and desserts was associated
with worse disease-free and overall survival. Patients in the
highest quintile of this Western pattern experienced nearly a
three times worse disease-free survival as compared with
those in the lowest quintile on that pattern. A prudent pattern
high in vegetables, fruits, poultry, and fish was not associ-
ated with colorectal cancer outcomes in this study [41].
As far as vitamin D is concerned, two prospective cohort
studies, the Nurses’Health Study and the Health Professionals
Follow-Up Study, showed a 40% to 50% lower risk with
higher 25(OH) vitamin D concentrations in serum for colo-
rectal cancer–specific mortality and all-cause mortality, re-
spectively [39]. In particular, colorectal cancer patients with
stage IV disease may be at risk of vitamin D deficiency [42].
Body Mass Index
Risk of colorectal cancer recurrence, all-cause mortality, and
colorectal cancer–specific mortality has been found to be
elevated for patients who are underweight as well as for those
who are overweight before or at the time of diagnosis, as
extensively reviewed [9, 12]. Recent analyses in the Cancer
Prevention Study nutrition cohort for these end points con-
firmed these findings [43]. However, higher postdiagnostic
BMI did not affect survival outcomes in that study [43], as is
observed in most [9], but not all, studies [44].
Abdominal adiposity may be more strongly associated
with colon cancer prognosis than BMI [45]. To our knowl-
edge, there are no recent studies on pre- and postdiagnostic
body composition and fat distribution and its association
with colorectal cancer outcome.
Physical Activity
Colorectal cancer patients who are regularly physically ac-
tive after diagnosis experience more favorable survival than
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those who are not [9, 14–16]. Prediagnostic physical activity
levels are not consistently associated with outcomes of
colorectal cancer [14]. However, those who increased levels
of physical activity after diagnosis, compared with those
who did not change, decreased their cancer-specific mortal-
ity and overall mortality [14].
Prostate Cancer
Diet
As recently reviewed by Davies et al. [20], the paucity of
data on dietary intake and prostate cancer outcome makes it
impossible to draw conclusions. In a prospective observa-
tional study (CaPSURE [Cancer of the Prostate Strategic
Urologic Research Endeavor]) among approximately 1,300
localized prostate cancer patients, postdiagnostic intakes of
specific foods were associated with an increased risk of
prostate cancer progression (whole egg and poultry with
skin) or a decreased risk (cruciferous vegetables), while
other foods did not show associations [46, 47].
Body Mass Index
Within a recent meta-analysis including 6 prospective stud-
ies with a total of more than 18,000 patients, a 5-kg/m2
increase in BMI was associated with 20% higher prostate
cancer–specific mortality [48]. Androgen deprivation thera-
py has been found to be associated with changes in body
composition similar to those induced by chemotherapy in
breast cancer [49], yet the consequences of these changes on
prostate cancer outcome have not been studied.
Physical Activity
Few studies focused on physical activity and prostate
cancer outcome [20]. Within the Health Professionals
Follow-Up Study, 2,705 men diagnosed with nonmeta-
static prostate cancer were prospectively observed [50].
Men who were physically active had a lower risk of all-
cause and prostate cancer–specific mortality. Men exer-
cising vigorously before and after diagnosis had the
lowest risk. The CaPSURE study showed that men who
walked briskly for 3 h/week or more had a 57% lower
rate of progression than men who walked at an easy pace
for less than 3 h/week [51].
Summarizing, the evidence linking adiposity and lack of
physical activity before and after diagnosis to worse breast,
colorectal, and possibly prostate cancer prognosis is starting
to become convincing. Up to now, data on dietary factors in
cancer prognosis appear less convincing.
Ongoing Challenges and Steps to Be Taken
Diet
A healthy diet is certainly recommendable to cancer
patients; however, we are not yet able to formulate
evidence-based guidelines for specific foods and nutrients.
To be able to do that, we need more observational data on
the influence of pre- and postdiagnostic diet on cancer
outcome to plan and conduct feasible and effective dietary
intervention trials among cancer survivors. We need more
information about what patients do after diagnosis. Do they
change? If yes, when and what do they change? An ongoing
prospective study among breast cancer survivors in the
United Kingdom (the DietCompLyf [The Role of Diet,
Complementary Treatments and Lifestyle in Breast Cancer
Survival] study) recently showed that the intake of fruits and
vegetables, whole grains, and lean sources of protein in-
creased significantly after diagnosis, while consumption of
high-fat and high-sugar products, red meat, coffee, some
alcoholic drinks, and refined grains significantly decreased
[52]. In this study, dietary habits were only assessed once—
1 year after diagnosis. We are currently evaluating the role
of diet in colorectal cancer recurrence and survival (the
COLON study). In this prospective study, we assess diet
and lifestyle habits at least four times (i.e., shortly after
diagnosis and 6 months, 2 years, and 5 years after diagnosis)
to be able to study changes in habits during and after
colorectal cancer treatment [53]. One of the important ques-
tions that remains unanswered is whether it makes a differ-
ence to change one’s diet after diagnosis.
Body Mass Index
Although results on adiposity appear convincing enough to
recommend weight loss or maintenance of a healthy weight to
cancer survivors, most results thus far come from observa-
tional studies rather than from randomized clinical trials [7]. It
appears that only a few survivors succeed in sustained weight
loss after diagnosis, which limits the power to detect the
effects of weight loss on the risk of recurrence. Ongoing and
future interventions will have to address whether weight loss
is beneficial for survivors. In the United States, the ENERGY
(Exercise and Nutrition to Enhance Recovery and Good
Health for You) trial is currently ongoing; within this random-
ized controlled trial among 800 breast cancer survivors, wom-
en are counseled to lose weight through increased physical
activity and a healthy diet (http://clinicaltrials.gov
[NCT01112839]). The ENERGY trial is designed as a van-
guard study for a fully powered trial of 2,500 women to
address the effect of the intervention on cancer outcomes.
The budget of the ENERGY trial (1.4 million dollars) high-
lights the extent of resources needed to perform interventions.
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However, if effective interventions will beneficially affect the
number of recurrences and other health parameters, the med-
ical care costs to these survivors will be reduced. Thus, future
research should also assess the costs and benefits of these
interventions.
An important point of discussion is the timing of the
intervention. The American Cancer Society recommends
that weight loss can already begin during cancer therapy
(in case women or men are seriously overweight) [54].
However, this is a matter of debate, as weight loss during
therapy can also be a sign of undernutrition and may lead to
cachexia. As therapy may induce sarcopenia, which may
increase the risk of several comorbidities, cancer recurrence,
as well as functional decline, it may be especially beneficial
to focus on preserving lean body mass, but also on muscle
strength, and not on weight loss as such during and after
therapy. The challenge is to convince women and men to
take part in these interventions during a period so emotion-
ally and physically demanding as cancer therapy.
Physical Activity
Recommendations on appropriate physical activity already
have been endorsed as an important part of cancer therapy
by several American (US National Comprehensive Cancer
Network, the American Cancer Society, and the American
College of Sports Medicine) [55] and European institutions.
Endurance as well as resistance exercise during active treat-
ment is encouraged. However, reports on exercise interven-
tion trials among cancer patients sometimes lack the
appropriate details on the precise exercise prescription and
adherence to the prescription, limiting the reproducibility of
the intervention and the ability to determine the dose of
exercise received by the participants [56]. Also, few inter-
vention studies have addressed exercise and a healthy diet at
the same time, although stronger effects may be expected
from this combination. In observational analyses of the
WHEL study, for instance, the combination of high physical
activity (~3 h/week) and a diet high in vegetables and fruit
(>5 daily servings) was associated with higher breast cancer
survival rates than adherence to only one or no healthy
behaviors [57]. From the patient perspective, it is best to
have a multidisciplinary lifestyle intervention to get the
largest possible benefit. From a scientific perspective, in-
sight into the contribution of all the different aspects of a
lifestyle program is desired.
For observational studies as well as interventions on diet,
BMI, and physical activity, a major challenge will be the
recruitment of diverse, representative samples of the popu-
lation at large [13]. For instance, it is very difficult to recruit
participants from all socioeconomic classes into observa-
tional or experimental studies after cancer survival, as more
highly educated, healthier cancer survivors are more likely
to participate. If we want to translate the findings from these
studies into practice, we must make sure that effective
lifestyle interventions are suitable, applicable, and afford-
able for cancer survivors from all socioeconomic classes.
For evidence-based recommendations to be formulated
for all cancer survivors, we do need more studies on other
types of cancer. Although there are some studies on cancer
of the endometrium, ovaries, head, and neck, evidence is too
limited to draw conclusions [21, 55, 58]. In general, but
especially for rarer cancers, (inter)national cooperation is
essential.
Conclusions
A healthy lifestyle, including a healthy diet and sufficient
physical activity, is certainly recommendable to cancer
patients during and after treatment. However, there remains
an urgent need for well-designed studies investigating the
effects of improved diet, weight management, and increased
physical activity on cancer survivorship. Whereas the over-
all influence of diet on cancer survival remains to be deter-
mined, studies on adiposity and physical activity can now
focus on more detailed aspects, such as the timing of expo-
sure and the specific dose/duration needed. Also, more
research is needed on the combination of different lifestyle
changes simultaneously. One of the most profound chal-
lenges will be to determine how to change one’s lifestyle
during treatment as well as for one’s life. Needless to say,
this ultimate challenge is not restricted to cancer patients.
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